1. Home
  2. ARDX vs PBI Comparison

ARDX vs PBI Comparison

Compare ARDX & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.98

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

HOLD

Current Price

$9.77

Market Cap

1.6B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
PBI
Founded
2007
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
PBI
Price
$5.98
$9.77
Analyst Decision
Strong Buy
Buy
Analyst Count
10
2
Target Price
$10.65
$12.00
AVG Volume (30 Days)
2.7M
2.9M
Earning Date
10-30-2025
10-29-2025
Dividend Yield
N/A
3.28%
EPS Growth
N/A
N/A
EPS
N/A
0.45
Revenue
$398,234,000.00
$1,931,125,000.00
Revenue This Year
$22.71
N/A
Revenue Next Year
$27.81
N/A
P/E Ratio
N/A
$23.13
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$6.88
52 Week High
$6.78
$13.11

Technical Indicators

Market Signals
Indicator
ARDX
PBI
Relative Strength Index (RSI) 57.69 46.90
Support Level $5.49 $9.45
Resistance Level $6.02 $10.08
Average True Range (ATR) 0.28 0.26
MACD 0.01 0.10
Stochastic Oscillator 75.00 72.12

Price Performance

Historical Comparison
ARDX
PBI

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.

Share on Social Networks: